A New Frontier in Drug Delivery: Optimizing Nanoparticle Synthesis for Therapeutics
A forthcoming review in the European Journal of Pharmaceutics and Biopharmaceutics examines the critical principles and applications of flash nanoprecipitation (FNP), a key technology for formulating poorly water-soluble drugs into stable nanoparticles. The process, which involves the rapid mixing of an organic solvent containing the drug with an anti-solvent, is highly sensitive to factors like mixing dynamics, solvent composition, and stabilizer selection. The authors, Wisdom Awuku and Bi-Botti Celestin Youan, synthesize current evidence to outline how these variables influence the size, stability, and encapsulation efficiency of the resulting nanocarriers. This optimization is crucial for developing next-generation drug delivery systems with improved bioavailability and targeted action.
Why it might matter to you: Advanced nanoparticle formulation techniques like FNP have direct implications for hematology, particularly for delivering novel agents in oncology and managing complex coagulation disorders. For a professional focused on the latest developments, understanding this enabling technology is key, as it underpins the creation of next-generation therapeutics for conditions like leukemia, lymphoma, and thrombotic diseases. Mastery of such formulation principles can inform both clinical trial design and the evaluation of emerging treatments that rely on sophisticated nanocarriers to enhance efficacy and reduce side effects.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
